{
    "Trade/Device Name(s)": [
        "VITEK\u00ae 2 Gram Negative Doxycycline",
        "VITEK\u00ae 2 AST-GN Doxycycline"
    ],
    "Submitter Information": "bioM\u00e9rieux, Inc.",
    "510(k) Number": "K121546",
    "Predicate Device Reference 510(k) Number(s)": [
        "K103752"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LON"
    ],
    "Summary Letter Date": "October 19, 2012",
    "Summary Letter Received Date": "October 22, 2012",
    "Submission Date": "May 24, 2012",
    "Regulation Number(s)": [
        "21 CFR 866.1645"
    ],
    "Regulation Name(s)": [
        "Fully Automated Short-Term Incubation Cycle Antimicrobial Susceptibility System"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Doxycycline"
    ],
    "Specimen Type(s)": [
        "Isolated colonies of Gram-negative bacilli",
        "Staphylococcus spp.",
        "Enterococcus spp.",
        "Streptococcus spp.",
        "S. pneumoniae",
        "Clinically significant yeast"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "VITEK\u00ae 2",
        "VITEK\u00ae 2 Compact"
    ],
    "Method(s)/Technology(ies)": [
        "Antimicrobial susceptibility testing",
        "Miniaturized doubling dilution",
        "MIC microdilution methodology"
    ],
    "Methodologies": [
        "Automated susceptibility testing",
        "Quantitative test",
        "Qualitative test"
    ],
    "Submission Type(s)": [
        "Reagent",
        "Card",
        "Panel"
    ],
    "Document Summary": "FDA 510(k) summary for VITEK\u00ae 2 Gram Negative Doxycycline antimicrobial susceptibility test using VITEK\u00ae 2 and VITEK\u00ae 2 Compact Systems",
    "Indications for Use Summary": "Intended for antimicrobial susceptibility testing of Gram-negative bacilli with VITEK\u00ae 2 and VITEK\u00ae 2 Compact Systems to determine in vitro susceptibility to doxycycline.",
    "fda_folder": "Microbiology"
}